Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Evangelos Digkas"'
Autor:
Cecilia Olsson Ladjevardi, Anthoula Koliadi, Viktoria Rydén, Ali Inan El-Naggar, Evangelos Digkas, Antonios Valachis, Gustav J. Ullenhag
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionCheckpoint inhibitors (CPI) are widely used in cancer treatment with a potential of causing immune-related adverse events (IRAEs). Several studies have reported a positive correlation between development of IRAEs and improved survival out
Externí odkaz:
https://doaj.org/article/b3986559b97a4869a10c9b6cd7761d49
Autor:
Cecilia Olsson Ladjevardi, Anthoula Koliadi, Viktoria Rydén, Ali Inan El‐Naggar, Evangelos Digkas, Antonios Valachis, Gustav J. Ullenhag
Publikováno v:
Cancer Medicine, Vol 12, Iss 12, Pp 13217-13224 (2023)
Abstract Objective Checkpoint inhibitors (CPIs) are in widespread clinical use. Little is known about which patients are at risk for developing toxicity. It is essential being able to identify patients with higher risk of experiencing immune‐relate
Externí odkaz:
https://doaj.org/article/c87ca4bb36bd4d5186531e1e763e90ed
Autor:
Björn Engelbrekt Wahlin, Ninja Övergaard, Stefan Peterson, Evangelos Digkas, Ingrid Glimelius, Ingemar Lagerlöf, Ann‐Sofie Johansson, Marzia Palma, Lotta Hansson, Johan Linderoth, Christina Goldkuhl, Daniel Molin
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 400-412 (2021)
Abstract Treatment for patients > 60 years with classical Hodgkin lymphoma (cHL) is problematic; there is no gold standard, and outcome is poor. Using the Swedish Lymphoma Registry, we analysed all Swedish patients diagnosed with cHL between 2000 and
Externí odkaz:
https://doaj.org/article/63302eca98bd48feaf9e6ae6bdbac5ba
Autor:
Antonios Valachis, Camilla Rosén, Anthoula Koliadi, Evangelos Digkas, Alice Gustavsson, Andreas Nearchou, Gustav J Ullenhag
Publikováno v:
OncoImmunology, Vol 10, Iss 1 (2021)
In international guidelines, influenza vaccination is recommended to cancer patients receiving antitumor treatment. Whether this recommendation should include patients treated with the recently introduced and now widely used checkpoint inhibitors (CP
Externí odkaz:
https://doaj.org/article/54380719334a43ee8c45ea5424f4c65b
Autor:
Evangelos Digkas, Johan Linderoth, Marzia Palma, Christina Goldkuhl, Daniel Molin, Ingrid Glimelius, Ingemar Lagerlöf, Lotta Hansson, Ninja Övergaard, Ann-Sofie Johansson, Björn E. Wahlin, Stefan Peterson
Publikováno v:
eJHaem. 2:400-412
Treatment for patients 60 years with classical Hodgkin lymphoma (cHL) is problematic; there is no gold standard, and outcome is poor. Using the Swedish Lymphoma Registry, we analysed all Swedish patients diagnosed with cHL between 2000 and 2014 (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69a78ac5bf57ec32725ef279c81b7b38
https://doi.org/10.1002/jha2.202
https://doi.org/10.1002/jha2.202
Background Both randomized controlled trials (RCTs) and real-world evidence (RWE) studies provide results regarding the efficacy and toxicity of checkpoint inhibitors in cancer patients. The results from these two sources are considered complementary
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c00e5c6bd53fe91b2622b5da3d53a9a
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-494996
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-494996
Autor:
Evangelos Digkas, Anna-Karin Wennstig, Andreas Nearchou, Cecilia Nilsson, Karin Nyström, Karlis Pauksens, Antonis Valachis, Therse Björkin Joona
Publikováno v:
Breast Cancer Research and Treatment
Background Despite the current recommendation for influenza vaccination in cancer patients with active oncological therapy, limited data are available on the efficacy of vaccination in cancer patients receiving targeted therapies. We aimed to investi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f86e08cebfa524f5f9800893256e996
https://pubmed.ncbi.nlm.nih.gov/32737713
https://pubmed.ncbi.nlm.nih.gov/32737713
Autor:
G Minopoulos, Petros Kouridakis, Nikolaos Lyratzopoulos, Theodoros Lialiaris, Evangelos Digkas, Alexandros Polychronidis, Georgios Kouklakis
Publikováno v:
Cancer and Clinical Oncology. 1
Gastric cancer is one of the most common lethal malignancy in global and survival mainly depends on prognosis. Sister Chromatid Exchanges (SCEs) assay is a very sensitive method of detecting chromosome fragility. The aim of our study was to determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::15a4093fda475f0fd3f50eda2e6bfb5b
https://doi.org/10.5539/cco.v1n1p148
https://doi.org/10.5539/cco.v1n1p148
Autor:
Evangelos Athanassiou, Konstantinos Natsis, Konstantinos Vlasis, Evangelos Digkas, Anastasios Beletsiotis, Alexandros Kouskoukis, Theodore Lialiaris, Efthymia Papathanasiou, Elisabeth Tiaka
Publikováno v:
Genetic testing and molecular biomarkers. 14(4)
Tourniquets are often used to provide a bloodless operating field. However, they carry the risk of adverse effects caused by DNA damage from the free radicals generated during postischemic reperfusion of the blood. The aim of this study was to evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48e25761be6150af8a90a0bef3bf9bde
https://pubmed.ncbi.nlm.nih.gov/20632894
https://pubmed.ncbi.nlm.nih.gov/20632894